One of my favorite science communicators, Alex Dainis, is in the middle of a short-form video series where she’s tasting every amino acid.
Each video is great, but her reaction to tasting cysteine is memorable. I am obsessed; you should give a couple of the videos a watch.
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday.
Ask for forgiveness, not permission
If you’re tuned into the health AI discussion online, you’re probably sick of hearing takes on Utah’s artificial intelligence pilot program, where Doctronic will authorize prescription renewals with AI.
It sounds great — a step toward letting AI do more things in a “sandbox” environment sanctioned by the state government. But what, exactly, is the legality of this program?
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
